Ophthalmic AI Research Lab

Your eyes reveal your health

EyeMap.ai applies deep learning to retinal imaging for early detection of AMD, diabetic retinopathy, glaucoma, and systemic conditions, turning a routine eye scan into a whole-body health screen.

3
Diseases detected from a single fundus image
80%
Of vision loss is preventable with early detection
Non-invasive
No drops, no contact
5 min
From image capture to report
Interdisciplinary research at the intersection of ophthalmology, computer vision, and clinical medicine

What you'll find here

This site is organised in layers โ€” from high-level institute information to project-specific technical content and participant-facing documentation.


Active research programmes

Our computational ophthalmology work spans diagnostic AI, longitudinal biomarker tracking, and assistive device development.

Retinal Biomarkers for Systemic Disease Detection Core Programme

The retina offers a unique, non-invasive window into the systemic vasculature. Our models analyse fundus photographs to detect early signs of AMD, diabetic retinopathy, and glaucomatous changes โ€” and to infer downstream risk for stroke and cardiovascular events.

View AI model documentation โ†’
Population-Scale Retinal Imaging Analysis UK Biobank

We are applying to access UK Biobank retinal imaging data to validate our diagnostic models across a large, diverse population. This collaboration will enable longitudinal analysis of retinal change and its relationship with incident disease.

Research overview โ†’
Assistive Technology for Visual Impairment Human-Computer Interaction

Parallel to diagnostic AI, we conduct research into devices that restore functional capability to individuals with visual impairment, including the peer-reviewed FingerReader 2.0 wearable reading system published in ACM IMWUT.

FingerReader 2.0 research page โ†’

UK Biobank Application

EyeMap.ai Labs is preparing a formal application for access to UK Biobank retinal imaging data. Our research programme is designed to meet UK Biobank's ethical and governance requirements, including open-science commitments and participant data protection obligations. Participant-facing documentation and data governance materials are available on this site.

Participant Information

Leadership

EyeMap.ai is led by researchers with backgrounds spanning AI for healthcare, clinical wearables, computer vision, and enterprise scaling.

A
Alexandru Dancu, PhD
Chief Technology Officer ยท Principal Investigator
Postdoctoral researcher in AI for healthcare. Specialised in clinical wearables, computer vision, and assistive technologies. Research background includes peer-reviewed research in computer-science.
LinkedIn profile โ†’
T
Tudor Popescu, PhD
Chief Executive Officer ยท Co-founder
Expert in scaling technology ventures. Previously scaled Tudor Tailor and Teilor Diamonds across European markets. Leads commercialisation strategy, partnerships, and clinical deployment.
LinkedIn profile โ†’

Recent news

๐Ÿ†

HealthON Hackathon โ€” 3rd Prize

December 2025. EyeMap.ai was awarded third place at the HealthON Hackathon, judged by the Romanian Health Minister Alexandru Rogobete, who tested the system live during the presentation.

๐ŸŽค

Medical Conference Talk โ€” Ophthalmology Session

EyeMap.ai presented on 24th April 2026 at the Ophthalmology Session of the National Conference on Technology & iHealth in Medicine. Talk title: EyeMap.ai โ€” Scalable Retinal Screening for Early Detection of Ophthalmic Pathologies.